Browse 6226 National Institutes of Health Grants below, sorted by the last date to apply.
Select a specific National Institutes of Health grant to read the full description of the opportunity, which includes the grant type, total award amount, eligible applicants, important deadlines, and official contact details.
If you wish to search for a specific keyword or view grants sorted by category, use the links on the left menu bar.
| Close Date | Grant Title | Agency |
| May 07, 2016 |
The Role of Extracellular RNA in Mediating the Health Effects of Alcohol (R21) |
National Institutes of Health |
| May 07, 2016 |
Outcome Measures for Use in Treatment Trials for Individuals with Intellectual and Developmental Disabilities (R01) |
National Institutes of Health |
| May 07, 2016 |
Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01) |
National Institutes of Health |
| May 07, 2016 |
Research on Autism Spectrum Disorders (R03) |
National Institutes of Health |
| May 07, 2016 |
Research on Autism Spectrum Disorders (R01) |
National Institutes of Health |
| May 07, 2016 |
Research on Autism Spectrum Disorders (R21) |
National Institutes of Health |
| May 07, 2016 |
Improvement of Animal Models and Development of Technologies for Stem Cell-Based Regenerative Medicine (SBIR)(R43/R44) |
National Institutes of Health |
| May 07, 2016 |
Improvement of Animal Models and Development of Technologies for Stem Cell-Based Regenerative Medicine (STTR)(R41/R42) |
National Institutes of Health |
| Apr 01, 2016 |
Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21) |
National Institutes of Health |
| Mar 25, 2016 |
Methods Development for Obtaining Comprehensive Genomic Information from Human Specimens that are Easy to Collect and Store (R43/R44) |
National Institutes of Health |
| Mar 07, 2016 |
Early-Stage Pharmacological Validation of Novel Targets and Accompanying Pre-Therapeutic Leads for Diseases of Interest to the NIDDK (R01) |
National Institutes of Health |
| Jan 13, 2016 |
NIAID Clinical Trial Planning Grant (R34) |
National Institutes of Health |
| Jan 13, 2016 |
NIAID Clinical Trial Implementation Grant (R01) |
National Institutes of Health |
| Jan 13, 2016 |
NIAID Clinical Trial Implementation Cooperative Agreement (U01) |
National Institutes of Health |
| Jan 07, 2016 |
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01) |
National Institutes of Health |
| Jan 07, 2016 |
Environmental Exposures and Health: Exploration of Non-Traditional Settings, (R21) |
National Institutes of Health |
| Jan 07, 2016 |
Environmental Exposures and Health: Exploration of Non-Traditional Settings, (R01) |
National Institutes of Health |
| Jan 07, 2016 |
Erythropoiesis: Components and Mechanisms (R01) |
National Institutes of Health |
| Jan 07, 2016 |
Renal Function and Chronic Kidney Disease in Aging (R21) |
National Institutes of Health |
| Jan 07, 2016 |
Technology Development for Protein Modeling (R01) |
National Institutes of Health |
|
|
| Jan 07, 2016 |
Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01) |
National Institutes of Health |
| Jan 07, 2016 |
Examination of Survivorship Care Planning Efficacy and Impact [R01] |
National Institutes of Health |
| Jan 07, 2016 |
Examination of Survivorship Care Planning Efficacy and Impact [R21] |
National Institutes of Health |
| Jan 07, 2016 |
HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R21) |
National Institutes of Health |
| Jan 07, 2016 |
HIV/AIDS, Drug Use, and Vulnerable Populations in the US (R01) |
National Institutes of Health |
| Jan 07, 2016 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) [R21] |
National Institutes of Health |
| Jan 07, 2016 |
Technology Development for High-Throughput Structural Biology Research (R01) |
National Institutes of Health |
| Jan 07, 2016 |
Drug Abuse Aspects of HIV/AIDS (R03) |
National Institutes of Health |
| Jan 07, 2016 |
Drug Abuse Aspects of HIV/AIDS (R21) |
National Institutes of Health |
| Jan 07, 2016 |
Drug Abuse Aspects of HIV/AIDS (R01) |
National Institutes of Health |
| Jan 07, 2016 |
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30) |
National Institutes of Health |
| Jan 07, 2016 |
Ancillary Studies of Acute Kidney Injury, Chronic Kidney Disease, and End Stage Renal Disease Accessing Information from Clinical Trials, Epidemiological Studies, and Databases (R01) |
National Institutes of Health |
| Jan 07, 2016 |
NHLBI Clinical Trial Pilot Studies (R34) |
National Institutes of Health |
| Jan 07, 2016 |
Prescription Drug Abuse (R21) |
National Institutes of Health |
| Jan 07, 2016 |
Prescription Drug Abuse (R01) |
National Institutes of Health |
| Jan 07, 2016 |
Solid Organ Transplantation: Older Donors and Recipients (R03) |
National Institutes of Health |
| Jan 07, 2016 |
Solid Organ Transplantation: Older Donors and Recipients (R01) |
National Institutes of Health |
| Jan 07, 2016 |
Solid Organ Transplantation: Older Donors and Recipients (R21) |
National Institutes of Health |
| Jan 07, 2016 |
NIA Clinical Trial Planning Grant Program (R34) |
National Institutes of Health |
| Jan 07, 2016 |
Calcium Oxalate Stone Diseases (R01) |
National Institutes of Health |
